IDEA Collider

About IDEA Collider

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. The podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare. Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking. Questions We Explore * What is asymmetric learning, and how does it fuel pharma innovation? * Why do some organizations outpace others—and what can we learn from them? * How can we overcome barriers to meaningful progress in healthcare? * What’s broken in traditional innovation models—and how do we fix it? 🎧 Listen and subscribe on all major platforms.

Publisher

IDEA Pharma, SAI MedPartners

Category

business · business · science

Language

en

Explicit

No

First episode

10 Sept 2019

Latest episode

7 Oct 2026

Latest episodes

20 of 75 episodes have a transcript.

1. 

   7 Oct 2026TRANSCRIPT

   AI-Driven Pharma Market Research: Synthetic Users - with Kwame Ferreira & Rebecca Gould.

   Host Rick Ritacco interviews Kwame Ferreira, Founder of Synthetic Users, and Rebecca Gould, President at SAI, exploring how AI-driven synthetic users revolutionize pharmaceutical market research for faster, higher-confidence decisions.

2. 

   14 Sept 2026TRANSCRIPT

   The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution: Part II

   Alex Gray interviews David Radwaner and Tom Brockbank about the future of immuno-oncology, exploring strategies for the post-Keytruda era and the evolution of cancer immunotherapy.

3. 

   16 Jul 2026TRANSCRIPT

   Targeting the Totality of MS: Jason Tardio on Immunic’s Combined Neuroprotective and Anti-Inflammatory Strategy

   Host Rick Ritacco interviews Jason Tardio, President and COO of Immunic, exploring their dual-mechanism therapy for Multiple Sclerosis, aiming to halt progression and achieve remyelination.

Inside a recent episode

AI-Driven Pharma Market Research: Synthetic Users - with Kwame Ferreira & Rebecca Gould.

Published 7 Oct 2026 · Transcript excerpt

[…] Rebecca, you laid out the range that a synthetic user can take on from patient to physician to payer to regulator to whoever we want to design. But Kwame, I was hoping you could help us define and understand what a synthetic user actually is in your own terms. What is a synthetic user? That's a good question. I've not been asked that before. Usually I get asked, like, why are you doing synthetic users? And how? How is it that you put all of these things together but the what i guess the the what is simple we're trying to recreate human behavior so syntactic user is an agent that behaves somewhat similarly to to its organic counterpart so the world we inhabit is one where we have synthetic users and organic users we are organic, and then we synthesize our behavior. […]

Who has been a guest on IDEA Collider

Names identified in recent episode analyses. Showing up to five guests.

• Kwame Ferreira
• Rebecca Gould
• David Radwaner
• Tom Brockbank
• Jason Tardio

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

2 ratings

Spotify

5.0 / 5

3 ratings

Podcast Authority Score: 44 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

74

Social presence

0

YouTube

0

Engagement

32

Contact IDEA Collider

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Shows with a similar audience

• 

  BioCentury This Week

• 

  Biotech Hangout

• 

  Citeline Podcasts

• 

  The Rest Is Politics

• 

  The Intelligence from The Economist

Questions about IDEA Collider